BE888533A - Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques, - Google Patents

Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques,

Info

Publication number
BE888533A
BE888533A BE0/204580A BE204580A BE888533A BE 888533 A BE888533 A BE 888533A BE 0/204580 A BE0/204580 A BE 0/204580A BE 204580 A BE204580 A BE 204580A BE 888533 A BE888533 A BE 888533A
Authority
BE
Belgium
Prior art keywords
treatment
methods
pharmaceutical compositions
dermal tissue
tissue inflammation
Prior art date
Application number
BE0/204580A
Other languages
English (en)
Inventor
A Boris
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BE888533A publication Critical patent/BE888533A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/204580A 1980-04-25 1981-04-23 Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques, BE888533A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14369980A 1980-04-25 1980-04-25

Publications (1)

Publication Number Publication Date
BE888533A true BE888533A (fr) 1981-10-23

Family

ID=22505204

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/204580A BE888533A (fr) 1980-04-25 1981-04-23 Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques,

Country Status (13)

Country Link
EP (1) EP0039059B1 (fr)
JP (1) JPS56167623A (fr)
AU (1) AU546086B2 (fr)
BE (1) BE888533A (fr)
CA (1) CA1172565A (fr)
DE (2) DE3116388A1 (fr)
DO (1) DOP1981003011A (fr)
IE (1) IE51990B1 (fr)
IL (1) IL62705A (fr)
NZ (1) NZ196898A (fr)
PH (2) PH17739A (fr)
ZA (1) ZA812735B (fr)
ZW (1) ZW9281A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA979441A (en) * 1967-02-27 1975-12-09 American Cyanamid Company 11-(piperazinyl) dibenz (b,f) (1,4) oxazepines and analogous thiazepines
NL137032C (fr) * 1967-03-28 Richardson Merrell Spa
CH539044A (de) * 1967-10-06 1973-08-31 Gnii Orch Poluproduktov I Kras Verfahren zur Herstellung quaternärer Ammoniumsalze von 1,3-Bis-(aminomethyl)-imidazolidonen
BE791348A (fr) * 1971-11-16 1973-05-14 Hoffmann La Roche Composes tricycliques
US4034087A (en) * 1973-12-17 1977-07-05 The Regents Of The University Of Michigan Pharmaceutical composition and process of treatment
DE2401446A1 (de) * 1973-01-16 1974-07-25 Voorhees Pharmazeutische zubereitungen zur linderung von hautproliferationserkrankungen
US4049809A (en) * 1976-11-24 1977-09-20 American Cyanamid Company Solution of a oxazepine for oral or parenteral administration

Also Published As

Publication number Publication date
ZW9281A1 (en) 1982-01-28
DE3116388A1 (de) 1982-06-24
PH17739A (en) 1984-11-23
AU546086B2 (en) 1985-08-15
EP0039059A3 (en) 1982-05-12
IL62705A (en) 1986-04-29
CA1172565A (fr) 1984-08-14
EP0039059B1 (fr) 1986-06-25
NZ196898A (en) 1984-05-31
DE3174873D1 (en) 1986-07-31
AU6981281A (en) 1981-10-29
IE810919L (en) 1981-10-25
JPS56167623A (en) 1981-12-23
PH18482A (en) 1985-07-18
IE51990B1 (en) 1987-05-13
EP0039059A2 (fr) 1981-11-04
DOP1981003011A (es) 1987-07-04
ZA812735B (en) 1982-04-28

Similar Documents

Publication Publication Date Title
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
BE890648A (fr) Compositions pour le traitement de l'acne
BE876157Q (fr) Medicament pour le traitement de l'acne
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
BE896027A (fr) Nouvelles glycoproteines, procedes de production et agents therapeutiques pour le traitement de tumeurs en contenant
BE889327A (fr) Preparations pharmaceutiques a base de peroxydes et d'erythromycines pour le traitement topique de l'acne
BE854416A (fr) Compositions pharmaceutiques pour le traitement des symptomes de la menopause et leur procede d'utilisation
FR2556348B1 (fr) Retinoides, leur preparation et leurs utilisations therapeutiques, notamment pour le traitement des neoplasies, de l'acne et du psoriasis
BE890433A (fr) Composition cosmetique pour le traitement local de la cellulite
FR2565493B1 (fr) Appareil d'electrotherapie, pour le traitement du cuir chevelu
FR2510889B1 (fr) Medicament contenant certains phosphates ribofurannosyl-3',5'-cycliques substitues en 6, 8 pour le traitement de maladies proliferatives de la peau
FR2612775B1 (fr) Compositions pour la prevention et le traitement de la degenerescence cutanee
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE871753A (fr) Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
BE860992A (fr) Composition et tampon pour le traitement ou la prevention de l'acne et d'affections de la peau similaires
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
BE888533A (fr) Compositions pharmaceutiques et procedes pour le traitement de l'inflammation de tissus dermiques,
FR2520230B1 (fr) Preparations medicamenteuses contenant un derive d'acide tetraiodothyro-carboxylique notamment pour le traitement de l'hypercholesterolemie
FR2640140B1 (fr) Compositions pour le traitement de phlebectasies et leur procede de preparation
EG14024A (en) Pharmaceutical compositions and their use in the profyloxis and or treatment of certain diseases

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE & CIE S.A.

Effective date: 19880430